13F-HR filed by EcoR1 Capital, LLC
EcoR1 Capital, LLC filed this 13F-HR for the quarter ended 2016-12-31, filed 2017-02-14, with 30 holding rows worth $299,240,000.
- Accession
- 0001140361-17-006794
- Filer
- CIK 1587114
- Filed
- 2017-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2016
A holdings report, 30 entries on the cover page, a total value of $299,240,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $299,240,000 with VALUE read as thousands by filing date, 13F file number 028-16764. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 2,855,515 | $43,661,000 | thousands by filing date | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 561,341 | $36,032,000 | thousands by filing date | |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 2,943,164 | $35,759,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 162,200 | $19,845,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 975,700 | $19,748,000 | thousands by filing date | |
| THERAVANCE BIOPHARMA | 88339KAA0 | NOTE 3.250%11/0 | 17,000,000 | $19,327,000 | thousands by filing date | principal |
| ARDELYX INC | 039697107 | COM | 1,296,836 | $18,415,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 2,611,906 | $15,410,000 | thousands by filing date | |
| FIVE PRIME THERAPEUTICS INC. | 33830X104 | Common Stock | 298,712 | $14,968,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 414,000 | $11,236,000 | thousands by filing date | |
| ALLERGAN PLC | G0177J908 | COM | 50,000 | $10,501,000 | thousands by filing date | call |
| EDITAS MEDICINE INC | 28106W103 | COM | 626,762 | $10,172,000 | thousands by filing date | |
| XENCOR INC | 98401F105 | COMMON STOCK | 375,000 | $9,870,000 | thousands by filing date | |
| CHIMERIX INC COM | 16934W106 | Stock | 1,415,687 | $6,512,000 | thousands by filing date | |
| FASTENAL CO | 311900954 | COM | 2,537,026 | $6,368,000 | thousands by filing date | |
| ATARA BIOTHERAPEUTICS INC COM NEW | 046513107 | Stock | 215,812 | $3,065,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 874,447 | $2,536,000 | thousands by filing date | |
| KINDRED BIOSCIENCES INC COM | 494577109 | Stock | 571,126 | $2,427,000 | thousands by filing date | |
| ATYR PHARMA INC | 002120103 | COM | 976,986 | $2,101,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 273,862 | $1,964,000 | thousands by filing date | |
| EGALET CORP | 28226B104 | COM | 222,300 | $1,701,000 | thousands by filing date | |
| NABRIVA THERAPEUTICS AG | 62957M104 | SPONSORED ADR | 264,773 | $1,578,000 | thousands by filing date | |
| DERMIRA INC | 24983L104 | COM | 43,200 | $1,310,000 | thousands by filing date | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 23,300 | $972,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 01683L106 | COM | 118,000 | $873,000 | thousands by filing date | |
| SYROS PHARMACEUTICALS INC | 87184Q107 | COM | 63,596 | $773,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 54,879 | $667,000 | thousands by filing date | |
| BIOPHARMX CORP | 09072X101 | COM | 1,342,000 | $502,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 8,560 | $500,000 | thousands by filing date | |
| CASCADIAN THERAPEUTICS INC | 14740B901 | COM | 103,800 | $447,000 | thousands by filing date | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001140361-17-006794 | this filing | 2017-02-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001140361-17-007745 | base | 2017-02-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001140361-17-007752 | added | 2017-02-15 | acceptance time not in the bulk data set |